A novel apoptosis-inducing mechanism of 5-aza-2'-deoxycitidine in melanoma cells: Demethylation of TNF-α and activation of FOXO1

Cancer Letters
Shunsuke NoguchiTakuya Mizuno

Abstract

Melanoma is a poor-prognosis cancer in both humans and dogs, and so the anti-tumor effects of 5-aza-2'-deoxycitidine (5-aza) on solid tumors such as melanoma have gained much attention. However, its anti-tumor mechanism remains entirely unclear. This present study revealed a part of the anti-tumor effects of 5-aza, focusing on apoptosis induction, on human and canine melanoma cells. Treatment with 5-aza markedly induced obvious apoptosis in melanoma cells. 5-Aza-induced apoptosis was possibly due to induced expression of cytotoxic cytokines such as TNF-α. We revealed hypermethylation of the promoter region of TNF-α as a consequence of treatment with 5-aza. Concurrently, we evaluated the effect of 5-aza on the Akt/FOXO1 signaling cascade, which plays a pivotal role in the transcription of cytokine genes. As a result, 5-aza inactivated Akt and inversely activated FOXO1, which contributed to the up-regulation of TNF-α. Furthermore, up-regulation of TNF-α by 5-aza administration was found in in vivo experiments. These current data suggest a novel apoptosis-inducing mechanism of 5-aza and indicate that 5-aza could be a promising therapeutic agent for the treatment of human and canine melanomas.

References

Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wade G AllemanJames R Vasselli
Jul 5, 2006·Cancer Research·Alireza MirmohammadsadeghUlrich R Hengge
May 20, 2008·Cell·Lai WangXiaodong Wang
Mar 29, 2011·Biochimica Et Biophysica Acta·Xinbo ZhangArun K Rishi
May 10, 2011·Cancer Letters·Syunsuke NoguchiYukihiro Akao
Jul 29, 2011·International Journal of Cancer. Journal International Du Cancer·Oscar AlcazarPierre Triozzi
Aug 2, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexander M M Eggermont, Caroline Robert
Apr 12, 2012·Molecular Biology of the Cell·Kathrin GeigerPetra Obexer
May 1, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shunsuke NoguchiYukihiro Akao
May 4, 2013·British Journal of Pharmacology·O MicheauF Dufour
Oct 12, 2013·Pigment Cell & Melanoma Research·Marc GillardCatherine André
Oct 17, 2013·Pigment Cell & Melanoma Research·R Mark SimpsonStephen M Hewitt
Nov 5, 2013·Critical Reviews in Oncology/hematology·Heidrun KarlicMichael Pfeilstöcker
Jan 7, 2014·Frontiers in Immunology·Denise L Faustman, Miriam Davis
Sep 3, 2014·Journal of Biochemistry·Yutaka Kondo
Sep 23, 2014·Blood·Rafael Bejar, David P Steensma

❮ Previous
Next ❯

Citations

Apr 22, 2017·Nanomedicine : Nanotechnology, Biology, and Medicine·Xiaoxiao LiuYuquan Wei
Nov 17, 2020·Frontiers in Oncology·Pedro Luiz Porfirio XavierHeidge Fukumasu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.